FibroBiologics Inc. (FBLG)
(Real Time Quote from BATS)
$5.83 USD
-0.37 (-5.97%)
Updated Jun 20, 2024 02:36 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
FBLG 5.83 -0.37(-5.97%)
Will FBLG be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for FBLG based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for FBLG
FibroBiologics files for 16.02M shares of common stock by selling shareholder
FibroBiologics files to sell 16.02M shares of common stock for holders
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Vail Resorts Posts Downbeat Q3 Results, Joins Concrete Pumping, DocuSign And Other Big Stocks Moving Lower In Friday's Pre-Market Session
12 Health Care Stocks Moving In Thursday's Intraday Session